期刊文献+

多发性骨髓瘤患者外周血CD4^+T淋巴细胞亚群特点研究 被引量:3

Study on the characteristics of CD4^+ T Lymphocyte subsets in peripheral blood from the patients with multiple myeloma
下载PDF
导出
摘要 目的研究多发性骨髓瘤(MM)患者外周血CD4+T淋巴细胞亚群特点。方法用流式细胞术检测30例MM初诊患者、20例治疗后患者及10名健康志愿者(对照组)外周血CD4+T淋巴细胞亚群,比较分析3组之间调节性T细胞(Treg)、辅助性T细胞(Th)1、Th17比例及Treg/Th17、Th1/Th17比值。结果初诊MM患者外周血Th17比例明显高于对照组,Treg、Th1比例及Treg/Th17、Th1/Th17比值明显低于对照组。治疗后患者Treg、Th1比例及Treg/Th17、Th1/Th17比值较治疗前明显提高,Th1及CD4+CD25+细胞比例基本恢复至对照组水平,CD4+Foxp3+细胞比例及Treg/Th17、Th1/Th17比值仍明显低于对照组。结论 MM患者外周血Th17细胞在初始T细胞的分化过程中取得了极化优势。治疗后Th17细胞极化优势现象明显改善,Th17细胞可能参与了MM的疾病进程。 Objective To study the characteristics of CD4+T lymphocyte subsets in peripheral blood from the patients with multiple myeloma(MM).Methods The CD4+ T lymphocytes subsets from the 30 cases in diagnosis the 20 post-treatment patients with MM and 10 healthy volunteers(control groups) were measured by flow cytometry,The percentage of Treg,Th1 and Th17 cells and the ratios of Treg/Th17,Th1/Th17 were analyzed among the three groups.Results The percentage of Th17 from the cases in diagnosis was clearly higher than that from healthy controls group.The percentage of Th1 and Treg,the ratios of Th1/Th17 and Treg/ Th17 from the cases in diagnosis were markedly lower than those from healthy controls group,and those index from the post-treatment cases were obviously higher than those from the cases in diagnosis.The percentage of Th1 and CD4+ CD25+ cells from the post-treatment cases recovered nearly to the levels of healthy controls,The percentage of CD4+Foxp3+ cells and the ratios of Th1/Th17 and Treg/Th17 from the post-treatment cases were still lower than those from healthy controls group.Conclusion Th17 cells in peripheral blood from patients with multiple myeloma make a polarizing advantage in the process of naive T cells differentiated into Th1,Treg and Th17.The polarizing advantage of Th17 cells is dramatically improved by treatment,and it is possible that Th17 cells are participated in the development of MM.
出处 《山西医药杂志(上半月)》 CAS 2011年第6期555-557,共3页 Shanxi Medical Journal
关键词 多发性骨髓瘤 辅助性T细胞 调节性T细胞 干扰素-Γ 白介素-6 白介素-17 Multiple myeloma Helper T cell Regulatory T Cells Interferon-γ Interleukin-6 Interleukin-17
  • 相关文献

参考文献8

  • 1Noonan K,Marchionni L,Anderson J,et al.A novel role of IL-17 producing lymphocytes in mediating lytic bone disease in multiple myeloma.Blood,2010,116(18):3554-3563.
  • 2Prabhala RH,Pelluru D,Fulciniti M,et al.Elevated IL-17 produced by TH17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma.Blood,2010,115(26):5385-5392.
  • 3Zhou L,Ivanov II,Spolski R,et al.IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways.Nat Immunol,2007,8(9):967-974.
  • 4常大雨,欧阳建,周荣富,许景艳,陈兵,杨永公,张启国,邵晓雁,关朝阳,徐勇.慢性特发性血小板减少性紫癜CD4+细胞亚群变化的特点[J].中华内科杂志,2010,49(3):213-216. 被引量:19
  • 5程正位,郑芳.溃疡性结肠炎患者外周血Th17/Treg免疫平衡的研究[J].临床内科杂志,2009,26(10):709-711. 被引量:9
  • 6韩文敏,邱国强,周民,任敏,谢晓宝.CD4^+CD25^(+/high)CD127^(low)Tregs及TGF-β在多发性骨髓瘤患者外周血的表达分析[J].细胞与分子免疫学杂志,2008,24(10):996-998. 被引量:8
  • 7Atanackovic D,Cao Y,Luetkens T,et al.CD4^+CD25^+FOXP3^+ T regulartory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.Haematologica.2008,93(3):423-430.
  • 8Bettelli E,Carrier Y,Gao W,et al.Reciprocal developmental pathways for the generation of pathogenic effctor TH17 and regulatory T cells.Nature,2006,441(7090):235-238.

二级参考文献22

共引文献33

同被引文献45

  • 1Knutson KL, Disis ML. Salazar LG. CD4 regulatory T cells inhuman cancer pathogenesis. Cancer Immunol and Immunother,2007, 56(3):271-285.
  • 2Filaci G, Fenoglio D,Fravega,M. et al. CD8+ CD28- Tregulatory lymphocytes inhibiting T cell proliferativeandcytotoxic functions infiltrate human cancers. J Immunol, 2007,179(7): 4323-4334.
  • 3Thomson CW,Lee BP,Zhang L. Double-negative regulatory Tcells: non-conventional regulators. Immunol Res.2006,35(1-2):163-178.
  • 4Gershon RK, Kondo K. Cell interactions in the induction oftolerance: the role of thymic lymphocytes. Immunology, 1970,18(5):723-737.
  • 5Prabhala RH,Neri P, Bae JE, et al. Dysfunctional T regulatorycells in multiple myeloma. Blood, 2006,107( 1) : 301-304.
  • 6Lioznov M, El-Cheikh J Jr, Hoffmann F,et al. Lenalidomide assalvage therapy after allo-SCT for multiple myeloma is effectiveand leads to an increase of activated NK ( NKp44 ( + ) ) and T(HLA~DR( +)) cells. Bone Marrow Transplantation, 2010,45(2); 349-353.
  • 7Prabhala RH, Pelluru D, Fulciniti M,et al. Elevated IL-17produced by TH17 cells promotes myeloma cell growth andinhibits immune function in multiple myeloma. Blood,2010,115(26): 5385-5392.
  • 8Dhodapkar KM, Barbuto S, Matthews P, et al. Dendritic cellsmediate the induction of polyfunctional human IL17-producingcells ( Thl7-1 cells)enriched in the bone marrow of patients withmyeloma. Blood,2008,112(7) : 2878-2885.
  • 9Noonan K,Marchionni L, Anderson J,et al. A novel role of IL-17-producing lymphocytes in mediating lytic bone disease inmultiple myeloma. Blood, 2010,116(18) : 3554-3563.
  • 10Gupta R,Ganeshan P, Hakim M, et al. Significantly reducedregulatory T cell population in patients with untreated multiplemyeloma. Leuk Res, 2011,35(7) : 874-878.

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部